Skip to main content
. 2025 Dec 16;9(4):98. doi: 10.3390/vision9040098
AL Axial length
ANOVA Analysis of variance
AVG Average height
BCVA Best-corrected visual acuity
BMI Body mass index
CS Contrast sensitivity
ETDRS Early Treatment Diabetic Retinopathy Study
LogMAR Logarithm of the minimum angle of resolution
MGI Mean grey intensity
MVP Mean vitreous peaks
Nd:YAG Neodymium-doped yttrium aluminum garnet
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells
PCO Posterior capsular opacity
PDR Proliferative diabetic retinopathy
PVD Posterior vitreous detachment
PVR Proliferative vitreoretinopathy
QS1 Questionnaire score 1 (floaters perception)
QS2 Questionnaire score 2 (daily activities interference)
QS3 Questionnaire score 3 (foreign body sensation)
QUS Quantitative ultrasound
ROI Region of interest
SVF Symptomatic vitreous floater